Established and emerging ancillary techniques in management of microbial keratitis: a review

The British Journal of Ophthalmology
Dana RobaeiStephanie Watson

Abstract

Microbial keratitis is a sight-threatening condition and an ocular emergency, because of the potential for rapid progression. Intensive topical antimicrobials are the mainstay and the gold standard of treatment for microbial keratitis. However, despite appropriate diagnosis and therapy, treatment failure is still common, and can result in significant morbidity due to corneal perforation and/or scarring. For this reason, clinicians continue to seek novel treatment techniques in order to expand the armamentarium of tools available to manage microbial keratitis, and in doing so improve clinical outcomes. In this review, we examine the evidence for some established, as well as a few emerging ancillary techniques used to manage microbial keratitis. These include topical corticosteroids, corneal collagen cross-linking, intrastromal antimicrobials, amniotic membrane transplantation and miscellaneous other techniques. Of these, collagen cross-linking shows some promise for selected cases of infectious keratitis, although more research in the area is required before it is accepted as mainstream treatment for this potentially blinding condition.

References

Jan 15, 1991·American Journal of Ophthalmology·M P UpadhyayJ P Whitcher
Sep 1, 1990·The British Journal of Ophthalmology·T R CarmichaelN H Welsh
Mar 1, 1989·Archives of Ophthalmology·A Y MatobaM S Osato
Feb 1, 1987·The British Journal of Ophthalmology·D J Coster, P R Badenoch
Sep 1, 1988·Journal of Cataract and Refractive Surgery·T P O'BrienJ D Gottsch
Nov 1, 1986·Current Eye Research·D M O'DayJ A Clanton
Jun 1, 1969·American Journal of Ophthalmology·S B Aronson, T E Moore
Jun 8, 1965·Biochimica Et Biophysica Acta·A TsugitaK Uehara
Dec 9, 1967·British Medical Journal·G M Jesner
Aug 1, 1995·The British Journal of Ophthalmology·B D Allan, J K Dart
Aug 6, 2000·American Journal of Ophthalmology·H DaneshvarW G Hodge
Sep 22, 2001·Journal of Perinatal Medicine·H L Halliday
Mar 29, 2002·Survey of Ophthalmology·C E WilloughbyS B Kaye
Apr 30, 2003·American Journal of Ophthalmology·Gregor WollensakTheo Seiler
Apr 27, 2004·Experimental Eye Research·M HalhalF Behar-Cohen
Jun 30, 2004·Investigative Ophthalmology & Visual Science·Derya Gulsen, Anuj Chauhan
Jul 17, 2004·Cornea·M Teresa Rodríguez-AresFrancisco Gude
Oct 23, 2004·Clinical & Experimental Ophthalmology·Reece C Hall, Malcolm J McKellar
Dec 18, 2004·Cornea·Anuradha Chowdhary, Kirti Singh
Dec 14, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Esther Eljarrat-Binstock, Abraham J Domb
Dec 14, 2005·Archives of Ophthalmology·Enrique Garcia-Valenzuela, C Diane Song
Dec 13, 2006·American Journal of Ophthalmology·David L YehNatalie A Afshari
Jan 2, 2007·Cornea·Jean-Jacques GicquelPaul Dighiero
Jan 4, 2008·Investigative Ophthalmology & Visual Science·Irina S BarequetMordechai Rosner
Mar 12, 2008·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Natalie A AfshariRon A Adelman
Oct 3, 2008·The British Journal of Ophthalmology·M SrinivasanN R Acharya
Jan 14, 2009·Archives of Ophthalmology·Elisabeth J Cohen
Mar 3, 2009·European Journal of Ophthalmology·Tommaso Micelli FerrariLuisa Micelli Ferrari
Mar 31, 2009·Expert Opinion on Drug Delivery·Thirumurthy Velpandian
Aug 8, 2009·American Journal of Ophthalmology·John K G DartSimon Kilvington
Sep 3, 2009·Clinical & Experimental Ophthalmology·Katherine MasselosMinas T Coroneo
Sep 16, 2009·Archives of Ophthalmology·Nisha R AcharyaThomas M Lietman
Sep 23, 2009·Cornea·Hosam ShehaScheffer C G Tseng
Feb 25, 2010·International Ophthalmology·Vandana JainSundaram Natarajan
Nov 26, 2010·Cornea·Karim MakdoumiSven Crafoord
Dec 18, 2010·The British Journal of Ophthalmology·Virender S Sangwan, Sayan Basu
Feb 2, 2011·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Jason BlairAllan Slomovic

❮ Previous
Next ❯

Citations

Aug 24, 2016·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·W Behrens-Baumann
Sep 30, 2016·Ocular Immunology and Inflammation·Emmett T CunninghamManfred Zierhut
Aug 23, 2020·Pharmaceutics·Prabhakar BastolaMatthew L Hirsch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.